查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602397

急性心室引流市場：依病患類型、應用分類 - 2025-2030 年全球預測

Acute External Ventricular Drain Market by Patient Type (Adult, Pediatric), Application (Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，急性心室引流市場價值為2.4346億美元，預計到2024年將達到2.6664億美元，複合年成長率為9.95%，到2030年將達到4.7319億美元，預計將達到1000萬美元。

急性腦室引流 (EVD) 系統是重要的設備，旨在將腦脊髓液 (CSF) 從腦室轉移並在創傷性腦損傷和水腦症。在需要快速介入以防止顱內壓增高導致的神經元損傷的急性臨床環境中，出現了對 EVD 的需求。 EVD 的主要應用是神經外科、加護病房和急診醫學，最終用戶包括醫院和神經專科中心。 EVD 市場的成長在很大程度上受到神經系統疾病盛行率上升、神經外科技術進步以及新興國家醫療保健基礎設施發展的影響。此外，日益成長的老年人口更容易患神經系統疾病，進一步推動了需求。該市場的主要消費者正在探索醫療預算不斷增加的開拓領域的潛在商機，並利用智慧監控系統整合等技術進步來增強護理。然而，由於安裝和維護成本高昂、潛在的感染風險以及缺乏有效處理這些系統的熟練專業人員，該市場面臨著限制。創新可以集中於開發具有增強安全性和監控能力的經濟高效且侵入性較小的 EVD 系統。也可以考慮研究降低感染風險並延長設備壽命的材料技術。也就是說，市場相關人員應強調培訓計劃，以應對嚴格的監管合規挑戰並提高 EVD 系統管理技能。 EVD 市場的高度專業化性質要求醫療設備製造商和醫療保健提供者不斷合作、促進創新並使服務適應不斷變化的臨床需求。總之，策略重點是降低成本、技術整合和擴展到新興市場，可以顯著提高市場滲透率和有效性。

主要市場統計
基準年[2023] 2.4346億美元
預測年份 [2024] 2.6664億美元
預測年份 [2030] 47319萬美元
複合年成長率（%） 9.95%

市場動態：快速發展的急性心室引流市場的關鍵市場洞察

供需的動態交互作用正在改變急性心室引流市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球非創傷性水腦症的盛行率
    • 監測和調整患者神經狀態的需要
    • 患者對微創醫療的傾向
  • 市場限制因素
    • 治療持續時間和時間的不確定性
  • 市場機會
    • EVD 植入中擴大使用即時超音波導航
    • 全球醫療旅遊的成長
  • 市場挑戰
    • 與急性心室引流相關的風險

波特五力：駕馭急性心室引流市場的策略工具

波特的五力框架是了解急性心室引流市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解急性心室引流市場的外部影響

外部宏觀環境因素在塑造急性心室引流市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解急性心室引流市場的競爭狀況

對急性心室引流市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣急性心室引流市場供應商的績效評估

FPNV定位矩陣是評估急性心室引流市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪急性心室引流市場的成功之路

對於希望加強在全球市場的影響力的公司來說，對急性心室引流市場進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 非外傷性水腦症的全球盛行率
      • 監測和管理患者神經狀況的需要
      • 患者傾向微創醫療程序
    • 抑制因素
      • 治療時間和持續時間未知
    • 機會
      • EVD 植入中更多地使用即時超音波導航
      • 世界各地的醫療旅遊活動增加
    • 任務
      • 與急性心室引流相關的風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按患者類型分類的急性心室引流市場

  • 成人用
  • 小兒科

第7章 急性心室引流市場：依應用分類

  • 腦出血
  • 非外傷性水腦症
  • 蜘蛛網膜下腔出血
  • 腦外傷

第8章北美和南美急性心室引流市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區急性心室引流市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的急性心室引流市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • B. Braun Medical Inc.
  • Bicakcilar Medical Devices Industry and Trade Inc.
  • Brain Navi Biotechnology Co., Ltd.
  • Cadila Pharmaceuticals Limited
  • Cook Group Incorporated
  • Dispomedica GmbH
  • Fuji Systems Co. Ltd.
  • G. Surgiwear Ltd.
  • Geistlich Pharma Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic Plc
  • Merit Medical Systems
  • Moller Medical Gmbh
  • Natus Medical Incorporated
  • Neuromedex GmbH
  • Nipro Corporation
  • Pfizer Inc.
  • Raumedic AG
  • Salvavidas Pharmaceutical Pvt. Ltd
  • Silmag SA
  • Sophysa SA
  • Spiegelberg Gmbh & Co. Kg
  • Wellong Instruments Co., Ltd.
  • Yushin Medical Co., Ltd.
Product Code: MRR-957C47F8FEC9

The Acute External Ventricular Drain Market was valued at USD 243.46 million in 2023, expected to reach USD 266.64 million in 2024, and is projected to grow at a CAGR of 9.95%, to USD 473.19 million by 2030.

Acute External Ventricular Drain (EVD) systems are critical devices designed for managing intracranial pressure by diverting cerebrospinal fluid (CSF) from the brain's ventricles in conditions like traumatic brain injury or hydrocephalus. The necessity of EVDs arises in acute clinical settings where rapid intervention is needed to prevent neuronal damage from increased intracranial pressure. These devices find primary applications in neurosurgery, intensive care units, and emergency medicine, serving end users such as hospitals and specialized neurological centers. The market growth for EVDs is significantly influenced by rising incidences of neurological disorders, advancements in neurosurgical procedures, and the increasing availability of healthcare infrastructure in emerging economies. Additionally, the rise in the geriatric population susceptible to neurological ailments further propels demand. Key consumers in the market can explore potential opportunities in untapped regions with growing healthcare budgets and leverage technological advancements like integrating smart monitoring systems for enhanced care. However, the market faces limitations in terms of high costs associated with installation and maintenance, potential risks of infection, and a shortage of skilled professionals to handle these systems effectively. Innovation could focus on developing cost-effective, lesser invasive EVD systems with enhanced safety and monitoring capabilities. The research could also explore material technologies that reduce infection risks and extend device longevity. Nonetheless, market players should address the challenges of stringent regulatory compliances and emphasize training programs to enhance skills in managing EVD systems. The nature of the EVD market is highly specialized, requiring continuous collaborations between medical device manufacturers and healthcare providers to foster innovations and tailor services to meet evolving clinical demands. In sum, a strategic focus on cost reduction, technological integration, and expanding into developing regions could significantly enhance market reach and effectiveness.

KEY MARKET STATISTICS
Base Year [2023] USD 243.46 million
Estimated Year [2024] USD 266.64 million
Forecast Year [2030] USD 473.19 million
CAGR (%) 9.95%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute External Ventricular Drain Market

The Acute External Ventricular Drain Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of non-traumatic hydrocephalus globally
    • Need for monitoring and regulating the neurologic status of patients
    • Inclination of patients toward minimally invasive medical procedures
  • Market Restraints
    • Uncertain time and duration of treatment
  • Market Opportunities
    • Rising use of real-time ultrasound navigation for EVD implantation
    • Increasing medical tourism activities worldwide
  • Market Challenges
    • Risks associated with acute external ventricular drain

Porter's Five Forces: A Strategic Tool for Navigating the Acute External Ventricular Drain Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute External Ventricular Drain Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute External Ventricular Drain Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute External Ventricular Drain Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute External Ventricular Drain Market

A detailed market share analysis in the Acute External Ventricular Drain Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute External Ventricular Drain Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute External Ventricular Drain Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute External Ventricular Drain Market

A strategic analysis of the Acute External Ventricular Drain Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include B. Braun Medical Inc., Bicakcilar Medical Devices Industry and Trade Inc., Brain Navi Biotechnology Co., Ltd., Cadila Pharmaceuticals Limited, Cook Group Incorporated, Dispomedica GmbH, Fuji Systems Co. Ltd., G. Surgiwear Ltd., Geistlich Pharma Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Merit Medical Systems, Moller Medical Gmbh, Natus Medical Incorporated, Neuromedex GmbH, Nipro Corporation, Pfizer Inc., Raumedic AG, Salvavidas Pharmaceutical Pvt. Ltd, Silmag S.A., Sophysa SA, Spiegelberg Gmbh & Co. Kg, Wellong Instruments Co., Ltd., and Yushin Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Patient Type, market is studied across Adult and Pediatric.
  • Based on Application, market is studied across Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage, and Traumatic Brain Injury.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of non-traumatic hydrocephalus globally
      • 5.1.1.2. Need for monitoring and regulating the neurologic status of patients
      • 5.1.1.3. Inclination of patients toward minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertain time and duration of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising use of real-time ultrasound navigation for EVD implantation
      • 5.1.3.2. Increasing medical tourism activities worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with acute external ventricular drain
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acute External Ventricular Drain Market, by Patient Type

  • 6.1. Introduction
  • 6.2. Adult
  • 6.3. Pediatric

7. Acute External Ventricular Drain Market, by Application

  • 7.1. Introduction
  • 7.2. Intracerebral Hemorrhage
  • 7.3. Non-Traumatic Hydrocephalus Conditions
  • 7.4. Subarachnoid Hemorrhage
  • 7.5. Traumatic Brain Injury

8. Americas Acute External Ventricular Drain Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Acute External Ventricular Drain Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Acute External Ventricular Drain Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Medical Inc.
  • 2. Bicakcilar Medical Devices Industry and Trade Inc.
  • 3. Brain Navi Biotechnology Co., Ltd.
  • 4. Cadila Pharmaceuticals Limited
  • 5. Cook Group Incorporated
  • 6. Dispomedica GmbH
  • 7. Fuji Systems Co. Ltd.
  • 8. G. Surgiwear Ltd.
  • 9. Geistlich Pharma Inc.
  • 10. Integra LifeSciences Corporation
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medtronic Plc
  • 13. Merit Medical Systems
  • 14. Moller Medical Gmbh
  • 15. Natus Medical Incorporated
  • 16. Neuromedex GmbH
  • 17. Nipro Corporation
  • 18. Pfizer Inc.
  • 19. Raumedic AG
  • 20. Salvavidas Pharmaceutical Pvt. Ltd
  • 21. Silmag S.A.
  • 22. Sophysa SA
  • 23. Spiegelberg Gmbh & Co. Kg
  • 24. Wellong Instruments Co., Ltd.
  • 25. Yushin Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET RESEARCH PROCESS
  • FIGURE 2. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS
  • TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACEREBRAL HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY NON-TRAUMATIC HYDROCEPHALUS CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023